GlassScriptPhysician profile
Amy V Coker
NPI 1699241844
$2,127.92
in general payments reported to CMS, 2019-2025
17 companies · $525 in 2025
The $525 reported for 2025 was more than what 75% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $77.35 · 2022: $215 · 2023: $524 · 2024: $786 · 2025: $525.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,836.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,835.55 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ironshore Pharmaceuticals INC. | $296.79 | 2022-2024 | Jornay Pm |
| Dexcom, INC. | $282.43 | 2023-2024 | Dexcom G6 Transmitter |
| Supernus Pharmaceuticals, INC. | $254.80 | 2024-2025 | Qelbree |
| Corium, LLC | $248.46 | 2021-2024 | Azstarys |
| Lilly USA, LLC | $195.13 | 2024-2025 | Zepbound, Mounjaro |
| Novo Nordisk INC | $189.43 | 2023-2025 | Wegovy, Ozempic, Rybelsus |
| Astrazeneca Pharmaceuticals LP | $137.67 | 2024-2025 | Breztri, Airsupra |
| Glaxosmithkline, LLC. | $104.87 | 2021-2025 | Bexsero, Pediarix |
| Idorsia Pharmaceuticals US INC | $89.32 | 2023 | Quviviq |
| Amgen INC. | $77.87 | 2025 | Repatha |
| Pfizer INC. | $72.57 | 2022-2023 | |
| Merck Sharp & Dohme LLC | $53.62 | 2022-2025 | Rotateq, Vaxneuvance, Vaxelis |
| Sanofi-Aventis U.S. LLC | $53.60 | 2022 | |
| Tris Pharma INC | $23.73 | 2025 | Dyanavel Xr |
| Collegium Pharmaceutical, INC. | $19.80 | 2025 | Jornay Pm |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $14.06 | 2024 | |
| Takeda Pharmaceuticals U.S.A., INC. | $13.77 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amy Coker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.